EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tegaserod Stimulates 5-HT4 Serotonin Receptors in the Isolated Human Atrium

Christin Hesse, Joachim Neumann, Valerie Compan, Evgeni Ponimaskin iD, Franziska E Müller iD, Britt Hofmann, Ulrich Gergs iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252011133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Christin Hesse und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, 06097 Halle, Germany. Hauptthemen laut MEDLINE: Receptors, Serotonin, 5-HT4, Heart Atria, Indoles, Serotonin 5-HT4 Receptor Agonists. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tegaserod (1-{[(5-methoxy-1H-indol-3-yl)methyliden]amino}-3-pentylguanidine) is a potent agonist at human recombinant 5-HT4 serotonin receptors. Consequently, tegaserod is utilized in the treatment of bowel diseases. The objective of this study was to test the hypothesis that tegaserod stimulates human cardiac atrial 5-HT4-receptors via cyclic adenosine monophosphate (cAMP)-dependent pathways. Tegaserod exerted positive inotropic effects (PIEs) and positive chronotropic effects (PCEs) in isolated left and right atrial preparations, respectively, from mice with cardiac-specific overexpression of the human 5-HT4 serotonin receptor (5-HT4-TG) in a concentration- and time-dependent manner. However, no effect was observed in the hearts of littermates of wild-type mice (WT). Western blot analysis revealed that the expression of 5-HT4 receptors was significantly higher in 5-HT4-TG mice compared to WT mice. The specificity of the signal for the 5-HT4 receptor was confirmed by the absence of the signal in the hearts of 5-HT4 receptor knockout mice. Furthermore, tegaserod increased the force of contraction (at concentrations as low as 10 nM), reduced the time of tension relaxation, and increased the rate of tension development in isolated electrically stimulated (at a rate of 60 beats per minute) human right atrial preparations (HAPs, obtained during open-heart surgery) when administered alone. The potency and efficacy of tegaserod to raise the force of contraction were enhanced in the presence of cilostamide, a phosphodiesterase III inhibitor. The positive inotropic effect of tegaserod in HAPs was found to be attenuated by the 5-HT4 serotonin receptor antagonist GR 125487 (0.1 µM). The efficacy of tegaserod (10 µM) in raising the force of contraction in HAPs was less pronounced than that of serotonin (10 µM) or isoprenaline (1 µM). Tegaserod shifted the concentration–response curve of the force of contraction to serotonin to the right in HAPs, indicating that it is a partial agonist at 5-HT4 serotonin receptors in this model. We propose that the mechanism of action of tegaserod in HAPs involves cAMP-dependent phosphorylation of cardiac regulatory proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Serotonin, 5-HT4Heart AtriaIndolesSerotonin 5-HT4 Receptor AgonistsAnimalsHumansMiceMice, KnockoutCyclic AMPMaleMyocardial Contraction

Stichwörter der Autor:innen

cardiac serotonin receptorshuman atriummouse atriumtegaserod

Substanzen

Receptors, Serotonin, 5-HT4tegaserodIndolesSerotonin 5-HT4 Receptor AgonistsCyclic AMP

Autor:innen und Institutionen

  • Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, 06097 Halle, Germany.
  • Brains' Laboratory Lsco, Department of Sciences, Nîmes University, 30021 Nîmes, France.
  • Cellular Neurophysiology, Center of Physiology, Hannover Medical School, 30625 Hannover, Germany.
  • Department of Cardiac Surgery, Mid-German Heart Center, University Hospital Halle, 06097 Halle, Germany.

ORCID-Profile: Evgeni Ponimaskin, Franziska E Müller, Ulrich Gergs

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Hesse, C., Neumann, J., Compan, V., Ponimaskin, E., Müller, F. E., Hofmann, B., & Gergs, U. (2024). Tegaserod Stimulates 5-HT4 Serotonin Receptors in the Isolated Human Atrium. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252011133

Vancouver

Hesse C, Neumann J, Compan V, Ponimaskin E, Müller FE, Hofmann B, et al. Tegaserod Stimulates 5-HT4 Serotonin Receptors in the Isolated Human Atrium. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252011133

BibTeX
@article{Hesse2024,
  author = {Hesse, Christin and Neumann, Joachim and Compan, Valerie and Ponimaskin, Evgeni and Müller, Franziska E and Hofmann, Britt and Gergs, Ulrich},
  title = {Tegaserod Stimulates 5-HT4 Serotonin Receptors in the Isolated Human Atrium},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252011133}
}
Kostenlos starten →